DUBAI: Reproductive healthcare has been projected to become a $21.6 billion industry by 2020, up from $9.3 billion in 2012 due to the rising infertility cases around the world, according to a research study accomplished by a reputed healthcare provider in the UAE.
On the patients’ side, Dr Gautam Allahbadia, author of many peer-reviewed articles instrumental in the development of new fertility-enhancing protocols, said, “The psychological, physical, emotional, and financial stress experienced by a couple undergoing (IVF) treatment is very high.”
Therefore, from his 26 years of exposure in the field of reproductive health and fertility issues, the best procedure he recommended is the IVF Lite.
“Mild stimulation (IVF Lite) represents a patient-friendly alternative to conventional IVF,” the Aster Hospital IVF & Women Clinic medical director said.
The facility is among the speciality care division of the Aster DM Healthcare conglomerate which completed the UAE study.
“If the patient is anxious about the side effects of hormones, she will be greatly relieved if she is offered minimal stimulation instead of the conventional aggressive regimen,” Allahabadia said.
He currently oversees 68 patients, 40 of which are undergoing IVF treatments.
The patients are from the UAE and Eastern Europe as well as Central and South Asia.
Of the 40 patients, 20 were suggested to go through the IVF Lite.
The other 20 are taking the conventional IVF because they have had recurrent miscarriages and failed IVF, are suffering from abnormal uterus conditions and any other form of medical concern or are into late pregnancy.
Saying that the only solution he could see for infertility is IVF as child-bearing in all countries cutting across social-economic-educational-political spheres is a pressure, Allahbadia said, “The decision of treatment is based on various medical factors. Each individual’s body responds differently to a treatment. Traditional IVF treatments can be given to all patients.”
“However, IVF Lite is preferred for its advantages of milder stimulations which reduce the risk of OHSS (ovarian hyperstimulation syndrome which could be fatal) and lower the risks of multiple pregnancies (multiple births),” he added.
According to Allahbadia, IVF Lite was developed after it had been noticed that the conventional IVF had become more burdensome to the patients bombarded with huge dosages of hormones for between 11 and 13 days every menstrual cycle.
IVF Lite was developed separately between seven and eight years back by two reproductive health experts.
From Japan was the late Dr Osamu Kato, “a pioneer and statesman in the development of natural and mild stimulation cycle, IVF, vitrification of unfertilized embryos and occytes banking for cancer patients” who set up clinics in the Philippines, US and China.
The other was American-Chinese Dr John Zhang who is enjoying immense success as a fertility specialist in New York.
Both discovered that the whitish to pale yellow crystalline powder chlomyphene citrate could be an effective IVF tablet.